Dolutegravir

ATC J05AJ03 · 10 markets · 64 records

Dolutegravir 10 markets · 64 records Forms

Filters

MarketAU 11 US 8 GB 8 CA 7 ES 7 TW 4 EU 4 CN 3 HK 3 MX 1

Kind

Strength

AU 11 records · 6 shown of 6 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

50 mgtabletTivicay also in US·GB·CA
+4Other 4 markets
ES TW CN MX

Combination products containing this ingredient

50 mgtablet CombinationDolutegravir 50 mg + Lamivudine 300 mgDovato also in US·GB·CA
+1Other 1 markets
ES
50 mgtablet CombinationDolutegravir 50 mg + Rilpivirine 25 mgJuluca also in US·GB·CA
50 mgtablet CombinationDolutegravir 50 mg + Rilpivirine Hydrochloride 27.5 mgJULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle unknown
50 mgtablet CombinationAbacavir 600 mg + Dolutegravir 50 mg + Lamivudine 300 mgTriumeq also in US·GB·CA
+1Other 1 markets
ES
50 mgtablet CombinationAbacavir Sulfate 702 mg + Dolutegravir 50 mg + Lamivudine 300 mgTRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle unknown

5 records · 0 manufacturers 5 registros · 0 fabricantes 5 个记录 · 0 个厂家 5 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Dovato ×6Juluca ×4Tivicay ×14Tivicay PD ×3Triumeq ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

US 8 records · 7 shown of 7 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

50 mgtabletTivicay also in AU·GB·CA
+4Other 4 markets
ES TW CN MX
5 mgtabletTivicay PD also in GB·CA·ES
+1Other 1 markets
CN
10 mgtabletTivicay also in GB·ES
25 mgtabletTivicay also in GB

Combination products containing this ingredient

50 mgtablet CombinationDolutegravir 50 mg + Lamivudine 300 mgDovato also in AU·GB·CA
+1Other 1 markets
ES
50 mgtablet CombinationDolutegravir 50 mg + Rilpivirine 25 mgJuluca also in AU·GB·CA
50 mgtablet CombinationAbacavir 600 mg + Dolutegravir 50 mg + Lamivudine 300 mgTriumeq also in AU·GB·CA
+1Other 1 markets
ES

GB 8 records · 8 shown of 8 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

50 mgtabletTivicay also in AU·US·CA
+4Other 4 markets
ES TW CN MX
5 mgtabletTivicay also in US·CA·ES
+1Other 1 markets
CN
10 mgtabletTivicay also in US·ES
25 mgtabletTivicay also in US

Combination products containing this ingredient

50 mgtablet CombinationDolutegravir 50 mg + Lamivudine 300 mgDovato also in AU·US·CA
+1Other 1 markets
ES
50 mgtablet CombinationDolutegravir 50 mg + Rilpivirine 25 mgJuluca also in AU·US·CA
50 mgtablet CombinationAbacavir 600 mg + Dolutegravir 50 mg + Lamivudine 300 mgTriumeq also in AU·US·CA
+1Other 1 markets
ES
5 mgtablet CombinationAbacavir 60 mg + Dolutegravir 5 mg + Lamivudine 30 mgTriumeq also in ES

CA 7 records · 5 shown of 5 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

50 mgtabletPMS-DOLUTEGRAVIR+2SANDOZ DOLUTEGRAVIR、Tivicay also in AU·US·GB
+4Other 4 markets
ES TW CN MX
5 mgtabletTivicay also in US·GB·ES
+1Other 1 markets
CN

Combination products containing this ingredient

50 mgtablet CombinationDolutegravir 50 mg + Lamivudine 300 mgDovato also in AU·US·GB
+1Other 1 markets
ES
50 mgtablet CombinationDolutegravir 50 mg + Rilpivirine 25 mgJuluca also in AU·US·GB
50 mgtablet CombinationAbacavir 600 mg + Dolutegravir 50 mg + Lamivudine 300 mgTriumeq also in AU·US·GB
+1Other 1 markets
ES

ES 7 records · 7 shown of 7 Source CIMA (AEMPS) · Data as of live

Only this ingredient

50 mgtabletTivicay also in AU·US·GB
+4Other 4 markets
CA TW CN MX
5 mgtabletTIVICAY DISPERSABLES also in US·GB·CA
+1Other 1 markets
CN
10 mgtabletTivicay also in US·GB

Combination products containing this ingredient

50 mgtablet CombinationDolutegravir 50 mg + Lamivudine 300 mgDovato also in AU·US·GB
+1Other 1 markets
CA
50 mgtablet CombinationDolutegravir 50 mg + RilpivirineJuluca
50 mgtablet CombinationAbacavir 600 mg + Dolutegravir 50 mg + Lamivudine 300 mgTriumeq also in AU·US·GB
+1Other 1 markets
CA
5 mgtablet CombinationAbacavir 60 mg + Dolutegravir 5 mg + Lamivudine 30 mgTRIUMEQ DISPERSABLES also in GB

TW 4 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

Only this ingredient

50 mgtabletTivicay+1汰威凱膜衣錠50毫克 also in AU·US·GB
+4Other 4 markets
CA ES CN MX

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Dovato ×6Juluca ×4Triumeq ×6三恩美膜衣錠 ×1洛瓦梭膜衣錠 ×1滋若愷膜衣錠 ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 4 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Dovato ×6Juluca ×4Tivicay ×7Triumeq ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

CN 3 records · 2 shown of 2 Source 国家医保局医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

50 mgtablet特威凯多替拉韦 also in AU·US·GB
+4Other 4 markets
CA ES TW MX
5 mgtabletManufacturer: ViiV HealthcareBV also in US·GB·CA
+1Other 1 markets
ES

HK 3 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Dovato ×6Tivicay ×7Triumeq ×6

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

MX 1 records · 1 shown of 1 Source COFEPRIS · Data as of annual

Only this ingredient

50 mgtabletTivicay PD also in AU·US·GB
+4Other 4 markets
CA ES TW CN

Side-by-side table

Strength / form / release	US	GB	CA	AU	CN	ES	MX	TW	HK	EU
50 mg tablet	Tivicay	Tivicay	PMS-DOLUTEGRAVIR SANDOZ DOLUTEGRAVIR Tivicay	Tivicay	特威凯多替拉韦	Tivicay	Tivicay PD	Tivicay 汰威凱膜衣錠50毫克	not recorded	not recorded
5 mg tablet	Tivicay PD	Tivicay	Tivicay	not recorded	Manufacturer: ViiV HealthcareBV	TIVICAY DISPERSABLES	not recorded	not recorded	not recorded	not recorded
10 mg tablet	Tivicay	Tivicay	not recorded	not recorded	not recorded	Tivicay	not recorded	not recorded	not recorded	not recorded
25 mg tablet	Tivicay	Tivicay	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
50 mg Combination Dolutegravir 50 mg + Lamivudine 300 mg tablet	Dovato	Dovato	Dovato	Dovato	not recorded	Dovato	not recorded	not recorded	not recorded	not recorded
50 mg Combination Dolutegravir 50 mg + Rilpivirine 25 mg tablet	Juluca	Juluca	Juluca	Juluca	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
50 mg Combination Dolutegravir 50 mg + Rilpivirine Hydrochloride 27.5 mg tablet	not recorded	not recorded	not recorded	JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
50 mg Combination Dolutegravir 50 mg + Rilpivirine tablet	not recorded	not recorded	not recorded	not recorded	not recorded	Juluca	not recorded	not recorded	not recorded	not recorded
50 mg Combination Abacavir 600 mg + Dolutegravir 50 mg + Lamivudine 300 mg tablet	Triumeq	Triumeq	Triumeq	Triumeq	not recorded	Triumeq	not recorded	not recorded	not recorded	not recorded
5 mg Combination Abacavir 60 mg + Dolutegravir 5 mg + Lamivudine 30 mg tablet	not recorded	Triumeq	not recorded	not recorded	not recorded	TRIUMEQ DISPERSABLES	not recorded	not recorded	not recorded	not recorded
50 mg Combination Abacavir Sulfate 702 mg + Dolutegravir 50 mg + Lamivudine 300 mg tablet	not recorded	not recorded	not recorded	TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottle	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Tivicay Tivicay PD	not recorded	not recorded	not recorded	not recorded	Tivicay	Tivicay
not disclosed Combination Dolutegravir + Lamivudine unknown	not recorded	not recorded	not recorded	Dovato	not recorded	not recorded	not recorded	not recorded	Dovato	Dovato
not disclosed Combination Dolutegravir + Lamivudine tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Dovato 洛瓦梭膜衣錠	not recorded	not recorded
not disclosed Combination Dolutegravir + Rilpivirine tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Juluca 滋若愷膜衣錠	not recorded	not recorded
not disclosed Combination Dolutegravir + Rilpivirine unknown	not recorded	not recorded	not recorded	Juluca	not recorded	not recorded	not recorded	not recorded	not recorded	Juluca
not disclosed Combination Abacavir + Dolutegravir + Lamivudine unknown	not recorded	not recorded	not recorded	Triumeq	not recorded	not recorded	not recorded	not recorded	Triumeq	Triumeq
not disclosed Combination Abacavir + Dolutegravir + Lamivudine tablet	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Triumeq 三恩美膜衣錠	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

4 more strength/form rows are recorded only in ES · TW and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en ES · TW que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 ES · TW 有记录（未在本表显示）。另有 4 個規格/劑型僅在 ES · TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

Dolutegravir

AU 11 records · 6 shown of 6 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

Combination products containing this ingredient

US 8 records · 7 shown of 7 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

Combination products containing this ingredient

GB 8 records · 8 shown of 8 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

Combination products containing this ingredient

CA 7 records · 5 shown of 5 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

Combination products containing this ingredient

ES 7 records · 7 shown of 7 Source CIMA (AEMPS) · Data as of live

Only this ingredient

Combination products containing this ingredient

TW 4 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

Only this ingredient

EU 4 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

CN 3 records · 2 shown of 2 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

Only this ingredient

HK 3 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

MX 1 records · 1 shown of 1 Source COFEPRIS · Data as of annual

Only this ingredient

CN 3 records · 2 shown of 2 Source 国家医保局医保药品分类与代码数据库 · Data as of 2025-04-04